6533b831fe1ef96bd1298637
RESEARCH PRODUCT
Dihydroisocoumarins, Naphthalenes, and Further Polyketides from Aloe vera and A. plicatilis: Isolation, Identification and Their 5-LOX/COX-1 Inhibiting Potency
K KuchtaRalf MaucherHw RauwaldGerd Dannhardtsubject
StereochemistrySize-exclusion chromatographydihydroisocoumarinsPharmaceutical ScienceAloinOrganic chemistry01 natural sciencesAloe emodin<i>Aloe plicatilis</i>Aloe veraAnalytical Chemistrychemistry.chemical_compoundQD241-441Drug DiscoveryStructural isomermedicinePotencyPhysical and Theoretical ChemistryAloe plicatilisanti-inflammatory activitynaphthalenesbiology<i>Aloe vera</i>010405 organic chemistryChemistrybiology.organism_classificationIn vitroCOX-1/5-LOX0104 chemical sciences010404 medicinal & biomolecular chemistryAloe vera; Aloe plicatilis; dihydroisocoumarins; naphthalenes; polyketides; anti-inflammatory activity; COX-1/5-LOXChemistry (miscellaneous)ddc:540Molecular Medicinemedicine.drugpolyketidesdescription
The present study aims at the isolation and identification of diverse phenolic polyketides from Aloe vera (L.) Burm.f. and Aloe plicatilis (L.) Miller and includes their 5-LOX/COX-1 inhibiting potency. After initial Sephadex-LH20 gel filtration and combined silica gel 60- and RP18-CC, three dihydroisocoumarins (nonaketides), four 5-methyl-8-C-glucosylchromones (heptaketides) from A. vera, and two hexaketide-naphthalenes from A. plicatilis have been isolated by means of HSCCC. The structures of all polyketides were elucidated by ESI-MS and 2D 1H/13C-NMR (HMQC, HMBC) techniques. The analytical/preparative separation of 3R-feralolide, 3′-O-β-d-glucopyranosyl- and the new 6-O-β-d-glucopyranosyl-3R-feralolide into their respective positional isomers are described here for the first time, including the assignment of the 3R-configuration in all feralolides by comparative CD spectroscopy. The chromones 7-O-methyl-aloesin and 7-O-methyl-aloeresin A were isolated for the first time from A. vera, together with the previously described aloesin (syn. aloeresin B) and aloeresin D. Furthermore, the new 5,6,7,8-tetrahydro-1-O-β-d-glucopyranosyl- 3,6R-dihydroxy-8R-methylnaphtalene was isolated from A. plicatilis, together with the known plicataloside. Subsequently, biological-pharmacological screening was performed to identify Aloe polyketides with anti-inflammatory potential in vitro. In addition to the above constituents, the anthranoids (octaketides) aloe emodin, aloin, 6′-(E)-p-coumaroyl-aloin A and B, and 6′-(E)-p-coumaroyl-7-hydroxy-8-O-methyl-aloin A and B were tested. In the COX-1 examination, only feralolide (10 µM) inhibited the formation of MDA by 24%, whereas the other polyketides did not display any inhibition at all. In the 5-LOX-test, all aloin-type anthranoids (10 µM) inhibited the formation of LTB4 by about 25–41%. Aloesin also displayed 10% inhibition at 10 µM in this in vitro setup, while the other chromones and naphthalenes did not display any activity. The present study, therefore, demonstrates the importance of low molecular phenolic polyketides for the known overall anti-inflammatory activity of Aloe vera preparations.
year | journal | country | edition | language |
---|---|---|---|---|
2021-07-12 | Molecules |